SILVER STD RES INC's ticker is SSRI and the CUSIP is 82823L106. A total of 124 filers reported holding SILVER STD RES INC in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,908,000 | +1809.7% | 505,450 | +993.1% | 0.06% | +1350.0% |
| Q1 2016 | $257,000 | +206.0% | 46,238 | +245.1% | 0.00% | +100.0% |
| Q2 2015 | $84,000 | -94.8% | 13,400 | -95.9% | 0.00% | -97.1% |
| Q4 2014 | $1,617,000 | +1485.3% | 323,173 | +1839.8% | 0.07% | +1280.0% |
| Q3 2014 | $102,000 | -94.8% | 16,660 | -94.8% | 0.01% | -93.5% |
| Q3 2013 | $1,958,000 | +1361.2% | 318,300 | +1400.4% | 0.08% | +1000.0% |
| Q2 2013 | $134,000 | – | 21,214 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syntal Capital Partners, LLC | 17,540 | $167,000 | 0.12% |